Reading: Early clinical experience with the new Amplatzer Ductal Occluder II for closure of the Persi...

Download

A- A+
dyslexia friendly

Research Papers

Early clinical experience with the new Amplatzer Ductal Occluder II for closure of the Persistent Arterial Duct (PDA)

Authors:

M. P. B. Goonetilleke ,

Teaching Hospital Karapitiya, Galle, LK
About M. P. B.
Paediatric Cardiology Unit
X close

A. U. Jayaratne,

Teaching Hospital Karapitiya, Galle, LK
About A. U.
Paediatric Cardiology Unit
X close

H. A. M. Inthisar,

Teaching Hospital Karapitiya, Galle, LK
About H. A. M.
Paediatric Cardiology Unit
X close

N. D. Vithanage,

Teaching Hospital Karapitiya, Galle, LK
About N. D.
Paediatric Cardiology Unit
X close

K. W. R. Wimalagunarathne,

Teaching Hospital Karapitiya, Galle, LK
About K. W. R.
Paediatric Cardiology Unit
X close

P. U. Janzs,

Teaching Hospital Karapitiya, Galle, LK
About P. U.
Paediatric Cardiology Unit
X close

A. D. Pathinayake,

Teaching Hospital Karapitiya, Galle, LK
About A. D.
Paediatric Cardiology Unit
X close

K. B. C. Anuruddha

Teaching Hospital Karapitiya, Galle, LK
About K. B. C.
Paediatric Cardiology Unit
X close

Abstract

Introduction: Transcatheter PDAclosure has gained acceptance over surgery because of its cosmetic benefits, shorter hospital stay and absence of pain associated with a thoracotomy. The Amplatzer Ductal Occluder II (ADOII) device provides a solution for the closure of small to moderate-sizedPDAs

Objective: To describe early single-centre clinical experience withADOII.

Methods: Children with a haemodynamically significant patent ductus arteriosus (PDA) who underwent percutaneous trans-pulmonary closure with Amplatzer Ductal Occluder II (ADO II) were included. Data was collected from computer based patient records.

Results: Trans-pulmonary PDAclosures usingADOII were undertaken in 65 children (46 females) with a mean age of 2years 3 months (range 5 months to 14 years) and a mean weight of 9.6kg (range 4.2-25kg).

Complete occlusion was noted pre-discharge in 64 (98.4%) patients. One (1.6%) had residual shunting after deployment followed by embolization to the left pulmonary artery on the third day of the procedure. Of the 65 children, five (7.7%) had mild flow acceleration in the left pulmonary artery and another one (1.6%) had mild aortic flow obstruction following the procedure.

 At 7 and 30 days, echocardiography confirmed complete ductal occlusion without need for further intervention in all 64 (98.4%) successful cases.

 Conclusions: ADO II is highly effective in rapid occlusion of morphologically varied small to moderate-sized PDAs.

DOI: http://doi.org/10.4038/gmj.v21i2.7952
How to Cite: Goonetilleke, M.P.B. et al., (2016). Early clinical experience with the new Amplatzer Ductal Occluder II for closure of the Persistent Arterial Duct (PDA). Galle Medical Journal. 21(2), pp.8–12. DOI: http://doi.org/10.4038/gmj.v21i2.7952
0
Views
0
Downloads
Published on 15 Dec 2016.
Peer Reviewed

Downloads

  • PDF (EN)

    comments powered by Disqus